Filing Details
- Accession Number:
- 0001209191-15-035508
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-22 16:01:44
- Reporting Period:
- 2015-04-20
- Filing Date:
- 2015-04-22
- Accepted Time:
- 2015-04-22 16:01:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1578432 | H. Mitchell Finer | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-04-20 | 1,166 | $2.09 | 1,166 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-04-20 | 13,834 | $5.50 | 15,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-04-20 | 2,520 | $123.53 | 12,480 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-04-20 | 1,689 | $124.71 | 10,791 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-04-20 | 5,457 | $125.62 | 5,334 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-04-20 | 750 | $126.68 | 4,584 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-04-20 | 3,875 | $127.84 | 709 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-04-20 | 11 | $128.25 | 698 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-04-20 | 628 | $130.57 | 70 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-04-20 | 70 | $131.29 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-04-20 | 900 | $0.00 | 900 | $2.09 |
Common Stock | Stock Option (right to buy) | Disposition | 2015-04-20 | 266 | $0.00 | 266 | $2.09 |
Common Stock | Stock Option (right to buy) | Disposition | 2015-04-20 | 8,384 | $0.00 | 8,384 | $5.50 |
Common Stock | Stock Option (right to buy) | Disposition | 2015-04-20 | 5,450 | $0.00 | 5,450 | $5.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-07-13 | No | 4 | M | Direct | |
0 | 2021-07-13 | No | 4 | M | Direct | |
30,371 | 2023-01-16 | No | 4 | M | Direct | |
114,364 | 2023-01-16 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2014.
- The range of prices for the transaction reported on this line was $123.14 to $124.08. The average weighted price was $123.5253. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $124.15 to $125.10. The average weighted price was $124.7060. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $125.21 to $126.18. The average weighted price was $125.6223. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $126.23 to $126.92. The average weighted price was $126.6818. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $127.2350 to $128.20. The average weighted price was $127.8359. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $130.00 to $131.00. The average weighted price was $130.5741. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $131.25 to $131.35. The average weighted price was $131.29. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests at a rate of twenty-five percent (25%) on April 15, 2012 and in 36 equal monthly installments thereafter.
- This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.
- This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of May 1, 2013. The shares underlying these options vested as follows: 25% vested on May 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.